▲ Up
 
17:10 20-09-2017
АКИpress CA-News Tazabek Turmush
ADVERTISE WITH US SUBSCRIBE
KazakhstanKyrgyzstanMongoliaTajikistanTurkmenistanUzbekistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Drug maker Shire rejects offer from AbbVie worth $46 billion
16:29, 20 June 2014, 1308

AKIPRESS.COM - drugs The Irish pharmaceutical company Shire said on Friday that it had rejected a takeover approach from the American drug maker AbbVie that valued the company at 27.2 billion pounds, or about $46.3 billion, the NY Times said. 

AbbVie, which is based in Chicago, revealed on Friday that it had first approached Shire in early May about a possible tie-up, but was rejected three times by Shire’s board of directors – the latest at the end of May. AbbVie was spun off from Abbott Laboratories last year.

Shire called AbbVie’s proposal “unsolicited and highly conditional” and said that it “fundamentally undervalued the company and its prospects.”

“We believe that Shire has a strong independent future,” Susan Kilsby, the Shire chairwoman, said in a statement.

Under British takeover rules, AbbVie has until July 18 to make a firm offer for Shire or walk away for at least six months before coming back with a further unsolicited offer. After three months, it is possible for the sides to reengage if Shire’s board agrees to it.

“There can be no certainty that any firm offer will be made,” AbbVie said in a statement. “Discussions are no longer ongoing.”

The latest cash and share offer was equal to £46.26 a share, AbbVie said.

Shire’s shares rose 13 percent to £42.26 in trading in London on Friday morning.


Full access to all news articles in English

1 month2000 somsubscribe
year20000 somsubscribe
These subscription fees are for private individuals only. Please contact us via phone +996 (312) 900-776 or email info@akipress.org for corporate subscription inquiries
Twitterfacebookprint
LATEST NEWS
16:59 Uzbekistan presents model of Samarkand's Registan Square to UN16:44 48 state-owned mansions near Ala-Archa state residence sold at auction for $2,074,00016:30 Mirziyoyev invites UN Chief to international conference on security and sustainable development in Central Asia16:25 Kazakh crime boss captured, he had fake Kyrgyz passport16:08 2 Election Commission members say there is consolidation of power ongoing in the commission16:01 Jalal-Abad man probed for killing brother15:53 Public prosecutor asks judge to sentence Aida Salyanova to 8 years in prison15:32 World Bank says drinking water of Tajikistan contains various bacteria15:28 Turkmenistan, Vietnam discuss expansion of cooperation15:21 'Government bodies must serve people,' Mirziyoyev says at UN assembly15:16 40% of country's GDP created by small and medium businesses in 2016: First Deputy PM15:02 Tajik anti-corruption officer jailed to 15 years on fraud, bribery charges14:58 OSCE and National Security Committee of Kyrgyzstan strengthen anti-terrorism cooperation14:47 Election Commission member says no violations in Nazarbayev-Babanov meeting14:45 Catalonia referendum: Spanish police target Catalan government14:35 Another checkpoint fully opens on Kyrgyz-Uzbek border14:26 Turkmenistan, Dominican Republic discuss bilateral cooperation14:12 Driver involved in fatal hit-and-run detained in Naryn14:10 United States donates over 13,000 books to libraries in Talas14:05 Kazakhstan, Russia ink nuclear energy cooperation deal
© AKIpress News Agency - 2001-2017. All rights reserved
Republication of any material is prohibited without a written agreement with AKIpress News Agency. Any citation must be accompanied by a hyperlink to akipress.com.
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75